Sam Smart

Sam Smart has a diverse work experience in finance and operations management. Sam began their career as a Life Sciences Consultant at PricewaterhouseCoopers in 1997, specializing in corporate finance and later transitioning to a role focused on consulting for life sciences companies. In 2008, they became a Consultant, taking on interim Finance Director and Financial Controller positions, utilizing their financial planning and critical thinking skills in entrepreneurial environments.

In subsequent years, Sam held various financial and leadership roles in biotech companies. Sam worked as a Consultant Finance Director at Iceni Diagnostics from 2018 to 2019, helping the company with financial matters. From 2014 to 2019, they served as the Finance Director at Glyconics Ltd, a diagnostics company specializing in respiratory disease. Sam also worked as a Financial Controller at Acacia Pharma Limited from 2014 to 2018, focusing on the development and commercialization of nausea and vomiting treatments for surgical and cancer patients. Additionally, they served as the Financial Controller at NodThera Limited from 2016 to 2018, where they played a key role in the company's successful Series A financing round.

More recently, Sam held roles at PBD Biotech Limited and EyeBio. At PBD Biotech Limited, from 2017 to 2020, they worked as a Consultant Finance Director, helping the company secure seed investment for its proprietary technology in the diagnosis of bacterial infections. Sam then joined EyeBio in 2021, first as the VP of Finance and later as a Consultant.

Sam'smost recent position was at Artios Pharma Ltd, where they held several roles. Sam started as a Financial Controller from 2018 to 2020 and then progressed to Head of Finance from 2020 to 2021. After that, they served as the Head of Operations from 2021 to 2022 and currently holds the position of Director of Operations.

Overall, Sam Smart's experience spans over two decades and encompasses financial planning, team building, fundraising, and strategic decision-making in the biotech industry.

Sam Smart completed their education in a chronological manner. They attended The Marist Schools from 1980 to 1990, though no specific degree or field of study was mentioned. In 1990, they enrolled in Heriot-Watt University, where they obtained a BSc (Hons) in Applied Microbiology, which they completed in 1994. Following this, from 1996 to 1997, Sam attended the University of Reading, where they earned an MSc in International Securities, Investment & Banking. In recent years, Sam pursued additional education at The Chartered Institute of Management Accountants. They first obtained a CIMA Certificate in Business Accounting from 2013 to 2014, and later completed a CIMA Diploma in Management Accounting from 2014 to 2015. No specific field of study was mentioned for these certification programs.